Connecting voluntary hepatitis B and C screening to obligatory tuberculosis screening for immigrants.
Recruiting
- Conditions
- jaundiceliver inflammation10047438
- Registration Number
- NL-OMON38977
- Lead Sponsor
- GGD Noord-en Oost-Gelderland
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 367
Inclusion Criteria
immigrant, eligible for obligatory tuberculosisscreening
> 18 years old
mentally competent
Exclusion Criteria
proven hepatitis B vaccination in the past
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>What is the prevalence of hepatitis B in the tested group?</p><br>
- Secondary Outcome Measures
Name Time Method <p>What is the prevalence of hepatitis C in the tested group?<br /><br>What percentage of the invited immigrants takes part in this screening?<br /><br>What percentage of the chronic hepatitis B and C carriers are referred to<br /><br>regular medical care?<br /><br>What are determinants of infection?<br /><br>What are reasons for non-participation?</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link hepatitis B/C co-infection to tuberculosis pathogenesis in immigrant populations?
How does combined hepatitis B/C and tuberculosis screening improve detection rates compared to isolated protocols?
Which biomarkers correlate with liver inflammation progression in hepatitis B/C co-infected TB patients?
What adverse events are associated with invasive hepatitis screening in TB-tested immigrant cohorts?
Are antiviral therapies for hepatitis B/C effective in TB co-infected patients with MeSH code 10047438?